Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Alleima invests in new facility in China to meet increasing demand in the Chemical and Petrochemical segment

Alleima is increasing its capacity for application tubing products, such as heat exchanger tubes, through an investment of approximately SEK 250 million in a new cold-finishing facility in Zhenjiang, China.The greenfield facility will have more than 10,000 square meters floor space and will be built on the existing Alleima site in Zhenjiang in China. Operations will ramp up from 2025, adding cold-finishing capabilities to meet the growing demand for heat exchangers, composite tubes and other application tubing products, mainly to the Chemical and Petrochemical segment in China. The facility

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT AUGUST 2023

Zinzino group revenue increased with a total of 13 %, compared with the previous year. The revenue in August for Zinzino's sales markets increased by 14 % and amounted to SEK 119.2 (104.3) million. Faun Pharma's external sales decreased by 1 % and amounted to SEK 7.5 (7.6) million. Overall, the Group increased revenues by 13 % to SEK 126.7 (111.9) million compared with the previous year. Accumulated revenue for January – August 2023 increased by 22 % to SEK 1078.8 (886.3) million. Revenues were distributed as follows: Regions,MSEK 23-Aug 22-Aug Change YTD 2023 YTD

Trailblazing the restaurant operations of tomorrow: Juvenes paves the way to a safer and more sustainable future

Dedicated to offering sustainable personnel and student restaurant services, Juvenes has embraced an active role in preserving nature and the environment. With Kiilto by their side, Juvenes has brought about substantial transformations through small everyday decisions – join us as we explore Juvenes' endeavors to secure a safe and sustainable future.The ripple effect of everyday choices is much more impressive than it might seem – especially when one decision is repeated thousands of times in a single day. At the heart of Juvenes, a provider of sustainable personnel and student restaurant

Sweco acquires engineering company OJ Rådgivende Ingeniører in Denmark, adding 325 experts in the building segment

Sweco today announces the acquisition of OJ Rådgivende Ingeniører, one of Denmark’s leading engineering firms in the buildings market. With the acquisition Sweco will almost double the size of its building business in Denmark and strengthen its position as a top engineering and architecture firm in the country.Photo, from left: Brian Thyregaard Andreasen, CEO OJ Rådgivende Ingeniører. Dariush Rezai, CEO Sweco Denmark. Photographer: Sweco. OJ Rådgivende Ingeniører A/S has both public and private clients in Denmark in the sectors of residential, healthcare, social housing, industry,

Read original

BioStock article: Aptahem's CEO comments on Q2 and looks ahead

For Aptahem, the second quarter continued to focus on the clinical development of drug candidate Apta-1 against sepsis. However, the company recently put the clinical phase Ia study on hold after making, what it called, interesting findings. BioStock talked to CEO Mikael Lindstam to get an update.Read the interview with Aptahem's CEO Mikael Lindstam at Aptahem’s website . For further information: Aptahem ABMikael Lindstam, CEOTel: +46 (0)766-33 36 99E-mail: ml@aptahem.com About Aptahem

Uniwater is expanding in the Nordic Region – establishing a branch in Finland

The water and wastewater group Uniwater is now stepping into the Finnish market. The subsidiary Ibeco, one of the Nordics’ leading distributors of water, wastewater and HVAC products, has opened a branch in Helsinki. This is an important and long-awaited step in the group's geographical expansion within the Nordic Region.Uniwater, a group with specialist companies in water infrastructure, is now expanding its platform in the Nordic Region by establishing the subsidiary Ibeco in Finland. Ibeco is one of the Nordics’ leading distributors of customer-specific water, wastewater and HVAC

PHI Strengthens Commitment to Regenerative Medicine through ARM and ATMP Sweden Membership

Phase Holographic Imaging (PHI) becomes a member of the leading international advocacy organization Alliance for Regenerative Medicine (ARM) as well as the national ATMP Sweden network to advocate for QPI technology for standard cell quality control in regenerative medicine.Following productive discussions over the summer, PHI is joining two influential organizations in the field of regenerative medicine. Discussions at the World Stem Cell Summit in Winston-Salem, where PHI participated in June this year, led to the Company joining ARM. As a next step in Sweden, PHI will attend the upcoming

All-season tire with the best winter properties – Nokian Tyres Hakkapeliitta TRI is made available in two more popular sizes for compact tractors and compact loaders

On the narrow city streets, crammed yards and residential areas, the small but powerful compact machines are the ideal choice for snow removal and other property maintenance work. The block-patterned Nokian Tyres Hakkapeliitta TRI M+S tire is now available in two more compact machine sizes, 400/70R18 for compact loaders and 250/80R16 for compact tractor front axles.Confident working in a built environment calls for agility and precise handling. Also, the transitions between worksites must be swift and comfortable. And when the winter strikes, the streets, yards and parking lots must be

NextCell Pharma presents at the Advanced Therapies Europe conference

NextCell Pharma participates in Advanced Therapies Europe, a European conference in Portugal on advanced cell therapies. NextCell's CSO Dr. Lindsay Davies will talk about NextCell's platform technology and the internationally recognized research generated during the development of drug product ProTrans for type 1 diabetes.NextCell Pharma was invited to present at the Advanced Therapies Europe conference, which will take place 5 – 7 September 2023 in Portugal. NextCell participates through CEO Mathias Svahn and CSO Lindsay Davies who will talk about NextCell's research with the cell therapy

Recipharm partners with Ahead Therapeutics to develop rare autoimmune disease therapy

Global contract development and manufacturing organisation (CDMO) Recipharm is partnering with Ahead Therapeutics to develop a ground-breaking treatment for a rare autoimmune disease, myasthenia gravis. Ahead Therapeutics is a Spanish start-up biotech company, using proprietary technology to develop treatments for different autoimmune disorders. Under the agreement, Recipharm will provide analytical and process development capabilities to support toxicology studies, as well as GLP manufacturing of lipid nanoparticles to encapsulate the active pharmaceutical ingredient, an antigen peptide.

Metsä Group’s Kemi mills are getting ready for the start-up of the investments

Metsä Group’s Kemi mills are getting ready for a maintenance and connection shutdown to prepare for the deployment of the largest ever investment of the forest industry in Finland – the new bioproduct mill and paperboard mill expansion in Kemi. The shutdown will begin on Sunday, 10 September 2023, and the aim is to start up the mills on 20 September 2023. During shutdown, odours may occur, and there may be temporary traffic congestion around the mill area, especially at the beginning of the week starting on 11 September. Odours may also occur before the shutdown due to preparations

Eficode grew 170% last financial year and propels forward with strong customer demand

Organizations’ needs for DevOps, Agile, cloud, and ITSM solutions and skills keep growing globally as all businesses become software companiesHelsinki, 5 September 2023 – Eficode grew organically and with acquisitions by over 170% in its last fiscal year, from 79,3 million euros to 189,6 million euros. Eficode’s compound annual growth (CAGR) during the previous four fiscal years has been 70%. During the past fiscal year, Eficode grew to nearly 600 employees and contracting consultants for DevOps, Agile, and associated tools and services. Eficode sees a strong connection between customers’

Read original

Contract awards for CSVs “Normand Baltic” and “Normand Samson”

Solstad Offshore ASA (“Solstad”) is pleased to announce the following new contract awards for two of its subsea vessels (CSV).   CSV “Normand Baltic” has been awarded a 180-day contract for providing “Walk to Work” services on Offshore Wind project in Asia. The contract will commence in October 2023.  CSV “Normand Samson” has been hired for a period of minimum 260 days to support a field development project in South America with commencement in 1Q24.   Commercial terms between the parties are in line with present market conditions for this type of vessels.  Solstad continues to

Half-year Results

EnQuest PLC Results for the six months ended 30 June 2023 5 September 2023 Unless otherwise stated, all figures are on a Business performance basis and are in US Dollars. Comparative figures for the Income statement relate to the period ended 30 June 2022 and the Balance sheet as at 31 December 2022. Alternative performance measures are reconciled within the 'Glossary - Non-GAAP measures' at the end of the Financial Statements. EnQuest Chief Executive, Amjad Bseisu, said: "Strong operational performance, including the efficient return to service of Kraken, has enabled free

BiBB receives approval of two patents in Europe for EndoDrill

The cancer diagnostics company BiBBInstruments AB ("BiBB or the "Company") today announces that the European Patent Office (EPO) has finally approved two patent applications for EndoDrill[®]. The patents provide broad protection of the EndoDrill[®] system until 2038 and 2039, respectively.The approvals relate to patent applications EP19780264.8 and EP18199230.6 from patent family 1 and follow previous Intention to Grants from the EPO announced in Q1 2023. The patents protect the EndoDrill[®] product series, the world's first market-cleared electric-driven biopsy instrument for endoscopy.

Betsson enters Serbia with online casino offering

Betsson today announces that the Group has been granted a license for the locally regulated online casino market in Serbia. Further, an online casino offering has been launched under the brand name Rizk. This initiative is aligned with Betsson’s strategy to grow through geographic expansion in new markets.   Betsson continues to strengthen its market presence in Central and Eastern Europe and Central Asia (CEECA). The CEECA region accounted for 43 percent of the Group’s revenue in the second quarter of 2023. A further step has now been taken as Betsson is entering the locally regulated

Epiroc and Kamoa Copper strengthen partnership in Democratic Republic of the Congo

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and construction industries, is continuing its successful partnership with Kamoa Copper SA in the Democratic Republic of the Congo. Epiroc has won its largest-ever order, for the expansion of the Kamoa-Kakula Copper Mining Complex.Kamoa Copper has ordered Minetruck MT65 S haulers, the world’s highest payload underground truck in the field, as well as Scooptram ST18 S loaders, Boomer 282 face drilling rigs, and Simba E70 S production drilling rigs. The machines will be used to expand operations at the

Polaris launches Polaris Public Equity – a Nordic fund focused on public companies with significant value-creation potential

Today, Polaris Management A/S (“Polaris”) launches Polaris Public Equity, a Nordic-focused fund targeting small and mid-sized public companies with significant value creation potential. Polaris Public Equity will hold significant ownership positions, often between 5 and 10 percent, with an investment horizon of 3 to 5 years, and will actively support management teams and other owners through a collaborative engagement strategy. By combining and leveraging private equity experience with public market competence, Polaris Public Equity will be able to realize the full potential of listed

Nordnet: Monthly statistics August

In August, 4,094,800 trades were made in listed financial instruments among Nordnet’s customers, which corresponds to 178,000 trades per day. The number of new customers in August amounted to 13,200 and the number of new customers in 2023 is 103,600. The total number of customers at the end of August was 1,811,400. Net savings for August was SEK 4.5 billion and the total net savings during 2023 is SEK 22.2 billion. The savings capital was SEK 808 billion and lending amounted to SEK 28.8 billion at the end of August.  +-----------------+---------+---------+---------+---------+--------+

Teleperformance Nordic Recognized as a Top 10 Company among Young Professionals in the 2023 Survey by Karriärföretagen

Teleperformance Nordic, a leading provider of digital business services, is proud to announce its award from Karriärföretagen. This prestigious recognition underlinesTeleperformance's commitment to creating and maintaining a dynamic and attractive workplace for emerging talents within the Nordic region.In the survey, conducted from May to July 2023, Karriärföretagen's extensive career network engaged 3,986 Young Professionals across various fields, including IT, Engineering, Economics, Social Sciences, Real Estate, and Law. These individuals, aged between 25 and 35, represent a diverse

BioStock: Aptahem's CEO comments on Q2 and looks ahead

For Aptahem, the second quarter continued to focus on the clinical development of drug candidate Apta-1 against sepsis. However, the company recently put the clinical phase Ia study on hold after making, what it called, interesting findings. BioStock talked to CEO Mikael Lindstam to get an update.Read the full interview with Mikael Lindstam at biostock.se: https://www.biostock.se/en/2023/09/aptahems-ceo-comments-on-q2-and-looks-ahead/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Sectra’s three-month interim report 2023/2024: Record-high order bookings

Press release – Linköping, September 5, 2023 – International medical imaging IT and cybersecurity company Sectra’s  (STO: SECT B) contracted order bookings exceeded SEK 2.9 billion during the quarter. Demand for the company’s customer offerings in both medical imaging IT and secure communication contributed to this historically high level for a single quarter. Net sales and recurring revenue are growing. Currency movements continued to have an advantageous effect on the company’s financial outcome and dampened the impact of ongoing investments in the transition to service

Nasdaq Stockholm delisting application

EnQuest PLC, 5 September 2023 EnQuest plans to apply for delisting of its shares from Nasdaq Stockholm EnQuest PLC ('EnQuest' or the 'Company') plans to apply for delisting of the Company's shares from Nasdaq Stockholm. The formal application for delisting will, however, be submitted to Nasdaq Stockholm no earlier than three months after the market has been informed of the delisting plans through this press release. The Company's shares will remain listed on the London Stock Exchange. EnQuest's listing on Nasdaq Stockholm originated from the issue of shares as consideration to

Director/PDMR Shareholdings

Capital for Colleagues plc / EPIC: CFCP / Market: AQSE / Sector: Financials   5 September 2023 CAPITAL FOR COLLEAGUES PLC (‘Capital for Colleagues’, ‘C4C’ or the ‘Company’)   DIRECTOR/PDMR SHAREHOLDINGS   Capital for Colleagues, the investment vehicle focused on opportunities in the Employee Owned Business (‘EOB’) sector, has been notified that C4C SIP Trustee Limited (the ‘Trustee’) has allocated a total of 20,814 existing ordinary shares of 40p each in the Company (‘Ordinary Shares’) to participants in the Company’s Share Incentive Plan (‘SIP’) at a price of 62.5p

There are no items matching the current filter
There are no more items matching the current filter
Back to top